• Exchange: London
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

Akers Biosciences Inc

+ Add to Watchlist

AKR:LN

285.0000 GBp 2.5000 0.87%

As of 11:30:00 ET on 07/11/2014.

Snapshot for Akers Biosciences Inc (AKR)

Open: 287.5000 Day's Range: 285.0000 - 287.5000 Volume: 314
Previous Close: 287.5000 52wk Range: 163.8000 - 690.3000 1-Yr Rtn: +73.99%

Stock Chart for AKR

No chart data available.
  • AKR:LN 285.0000
  • 1D
  • 1M
  • 1Y
287.5000
Interactive AKR Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for AKR

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. UKX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) -0.4900
Est. PEG Ratio -
Market Cap (M GBP) 13.95
Shares Outstanding (M) 4.89
30 Day Average Volume 1,601
Price/Book (mrq) 1.4369
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 09/10/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for AKR

No data available

Company Profile & Key Executives for AKR

Akers Biosciences, Inc. develops diagnostic kits. The Company produces kits that screen blood, urine, or saliva to rapidly diagnose HIV, hepatitis B, lyme disease, sexually transmitted diseases, mononucleosis, rheumatoid arthritis, hepatitis C, malaria and the presence of alcohol and several drugs. The kits can be used in clinics, hospitals, and doctors' offices.

Raymond F Akers JrChairman/President/CEO/Co-FounderGary RauchTreasurer/Controller
More Company Profile & Key Executives for AKR

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
  • AKR News

  • Industry News

Advertisement
Sponsored Links
Advertisements
sec ||= nil